Single-dose oral challenge safely clears drug allergy labels in outpatients
A prospective single-centre study found that 97 percent of 304 outpatients with low-risk drug allergy labels had no reaction during ...
A prospective single-centre study found that 97 percent of 304 outpatients with low-risk drug allergy labels had no reaction during ...
A Canadian cost analysis estimates that penicillin allergy de-labelling programs could save up to $6,581 per patient over a lifetime ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.